INT325678

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.02
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.80
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (Gcg) extracellular region (Gcg) cytoplasm (Gcg)
Gcg (Rattus norvegicus)
Pain Link Frequency Relevance Heat
corticosteroid 1 5.00 Very Low Very Low Very Low
Inflammation 1 5.00 Very Low Very Low Very Low
Angina 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Diabetes Mellitus 21 99.92 Very High Very High Very High
Hypoglycemia 8 91.32 High High
Weight Gain 1 66.56 Quite High
Obesity 7 5.00 Very Low Very Low Very Low
Body Weight 7 5.00 Very Low Very Low Very Low
Disorder Of Lipid Metabolism 6 5.00 Very Low Very Low Very Low
Cardiovascular Disease 2 5.00 Very Low Very Low Very Low
Syncope 1 5.00 Very Low Very Low Very Low
Hypertension 1 5.00 Very Low Very Low Very Low
Nasopharyngitis 1 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The development of dipeptidyl peptidase-IV (DPP-4) inhibitors, such as vildagliptin, has led to the improvement in glycaemic control in T2D by preventing the degradation of the incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide.
Negative_regulation (preventing) of Protein_catabolism (degradation) of glucagon-like peptide-1 associated with diabetes mellitus
1) Confidence 0.02 Published 2010 Journal Diabetes, Obesity & Metabolism Section Body Doc Link PMC2916214 Disease Relevance 0.80 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox